Import unapproved medicine into Guam
Importing medicines into Guam
View English version
Importing Unapproved Life-saving Medicine into Guam under the Federal Food, Drug, and Cosmetic Act (1938)
The Federal Food, Drug, and Cosmetic Act (FD&C Act) of 1938 establishes the legal framework through which the U.S. Food and Drug Administration (FDA) regulates the safety, efficacy, and security of food, drugs, and cosmetics within the United States and its territories, including Guam. This act was enacted to protect public health by ensuring that foods are pure and wholesome, drugs and medical devices are safe and effective, and cosmetics are safe for use. Under this comprehensive legislation, the importation of unapproved drugs poses significant regulatory challenges, particularly when individuals seek access to life-saving medications that are unavailable domestically.
Understanding Unapproved Drugs
An unapproved drug is any medication that has not been approved by the FDA for sale in the United States. This includes drugs that may be approved in other countries but have not undergone the rigorous FDA approval process, which evaluates the drug's safety, efficacy, and manufacturing quality. The FDA's approval process is essential for protecting consumers from ineffective or harmful medications.
Importing unapproved drugs circumvents this regulatory oversight, potentially exposing individuals to products that may not meet U.S. safety standards. Therefore, the FD&C Act generally prohibits the importation of these drugs to safeguard public health.
Exceptions Under the Personal Importation Policy
Recognizing the unique needs of individuals with serious or life-threatening conditions, the FDA has established a Personal Importation Policy. This policy allows for the discretionary enforcement of the FD&C Act in certain cases where importing unapproved drugs may be justified for personal use. It is important to note that this policy is not codified in law but serves as guidance for FDA staff in exercising enforcement discretion.
Detailed Criteria for Importation
To qualify under the Personal Importation Policy, the following detailed criteria must be satisfied:
- Intended Use: The drug is clearly intended for personal use, not for commercial distribution or resale. Evidence of personal use may include documentation such as a personal prescription or a letter from a healthcare provider.
- Serious Condition: The medical condition is serious or life-threatening, and there is no effective FDA-approved treatment available in Guam. This includes situations where available treatments have been ineffective or cause intolerable side effects.
- No Marketing or Promotion: The drug is not being actively marketed or promoted to U.S. residents. Importation should be initiated by the individual, not through solicitation by foreign suppliers.
- Risk Assessment: The medication does not pose an unreasonable risk to the individual. Factors considered include the drug's safety profile, potential for misuse, and the individual's medical history.
- Affirmation of Use: The individual importing the drug affirms in writing that it is for their own use. This affirmation may include a statement acknowledging the personal use and the necessity of the medication.
- Supporting Documentation: The individual provides the name and address of a licensed physician in the United States responsible for their treatment, or evidence that the product is for the continuation of a treatment begun in a foreign country.
By meeting these criteria, individuals may increase the likelihood that the FDA will exercise discretion and allow the importation of the unapproved medication.
Steps to Import Unapproved Medicine for Personal Use
Step 1: Obtain a Prescription and Medical Documentation
The first step involves consulting with a licensed healthcare provider who can attest to the necessity of the unapproved medication. The provider should document:
- The diagnosis of the serious or life-threatening condition.
- The lack of effective FDA-approved alternatives available in Guam.
- The anticipated benefits of the unapproved medication.
- A prescription for the medication, including dosage and administration instructions.
Step 2: Prepare a Personal Statement
The individual should prepare a signed statement addressing:
- Affirmation that the medication is intended solely for personal use.
- Acknowledgment of understanding that the medication is unapproved by the FDA.
- Consent to assume any risks associated with using the unapproved medication.
Step 3: Gather Supporting Documentation
In addition to the prescription and personal statement, the individual should collect:
- Contact information for the prescribing physician, including license number.
- Medical records or history that support the use of the unapproved medication.
- Information about the medication, such as the manufacturer, country of origin, and evidence of its approval in other countries.
Step 4: Declare the Medication Upon Entry
When bringing the medication into Guam, the individual must declare it to U.S. Customs and Border Protection (CBP) officers. This involves:
- Presenting all documentation to CBP officers for review.
- Answering any questions regarding the medication and its intended use.
- Understanding that the ultimate decision rests with the FDA and CBP authorities, who may detain or refuse the medication.
Role of U.S. Customs and Border Protection
CBP enforces customs laws and regulations, including those related to the importation of medications. CBP officers work in conjunction with the FDA to determine the admissibility of imported drugs. The process includes:
- Inspecting the medication and accompanying documentation.
- Assessing compliance with importation policies.
- Consulting with FDA representatives as necessary.
Individuals should be prepared for possible delays or inquiries during this process.
Controlled Substances Considerations
Certain medications may be classified as controlled substances, which are subject to strict regulations under the Controlled Substances Act. Importing controlled substances without proper authorization is illegal and can result in severe penalties. To determine if a medication is a controlled substance, individuals can reference the Drug Enforcement Administration (DEA)'s schedules of controlled substances.
Importation of controlled substances typically requires:
- Specific import permits or licenses.
- Compliance with DEA regulations.
- Adherence to quota limitations.
Alternative Access to Unapproved Medications
If importing the medication is not feasible, individuals may explore alternative options:
Expanded Access Programs
Expanded access, also known as compassionate use, allows patients with serious or life-threatening illnesses to access investigational drugs outside of clinical trials when no comparable alternatives are available. This requires cooperation from the drug manufacturer and approval from the FDA.
More information on expanded access can be found here: FDA Expanded Access Programs.
Clinical Trials Participation
Enrolling in a clinical trial provides access to investigational medications while contributing to medical research. Information about ongoing clinical trials can be found at ClinicalTrials.gov.
Special Import or Treatment INDs
Physicians may apply for a Treatment Investigational New Drug (IND) application to obtain unapproved medications for patients. This process involves FDA review and approval.
Legal Implications and Compliance
Non-compliance with importation laws can result in:
- Seizure and destruction of the medication.
- Fines or penalties.
- Potential criminal charges in severe cases.
Individuals must ensure that all actions comply with federal regulations to avoid legal repercussions.
Local Regulations in Guam
In addition to federal laws, Guam may have local regulations governing the importation and use of medications. Individuals should consult with local authorities or legal counsel to understand any additional requirements or restrictions.
Importance of Verifying Medication Authenticity
When sourcing medication from foreign suppliers, there is a risk of receiving counterfeit or substandard products. To mitigate this risk:
- Verify the legitimacy of the supplier and manufacturer.
- Ensure that the medication is sourced from reputable pharmacies or distributors.
- Check for proper labeling, packaging, and expiration dates.
The FDA does not regulate foreign pharmacies, so due diligence is essential.
Insurance and Cost Considerations
Importing medication may not be covered by insurance plans. Individuals should consider the financial costs, including:
- Price of the medication.
- Shipping and handling fees.
- Potential customs duties or taxes.
Financial assistance programs or charitable organizations may offer support for accessing necessary medications.
Patient Advocacy and Support
Patient advocacy groups can provide resources and support for individuals seeking access to unapproved medications. These organizations may offer:
- Information on treatment options.
- Assistance with navigating regulatory processes.
- Connections to clinical trials or expanded access programs.
Engaging with these groups can provide valuable guidance.
Maintaining Communication with Healthcare Providers
Continuous communication with healthcare providers is crucial. Providers can:
- Monitor the patient's condition and response to the medication.
- Adjust treatment plans as necessary.
- Report adverse effects to appropriate authorities.
Collaboration ensures the safe and effective use of the imported medication.
Regulatory Updates and Changes
Laws and policies regarding drug importation can change. Individuals should stay informed about current regulations by:
- Regularly checking official government websites.
- Subscribing to updates from the FDA and CBP.
- Consulting legal professionals when necessary.
Summary
Importing unapproved life-saving medication into Guam requires careful adherence to federal regulations under the FD&C Act of 1938. While the FDA's Personal Importation Policy provides a potential pathway for personal importation, it involves a complex set of criteria and procedures. Individuals must undertake thorough preparation, including obtaining necessary documentation, understanding legal obligations, and assessing potential risks. Engaging with healthcare providers and staying informed about regulatory requirements is essential for navigating this process successfully.